“Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study”, IJPRMH, vol. 1, no. 1, pp. 10–19, Sep. 2025, doi: 10.66328/ijprmh.2025.010103.